查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1518671

2024-2032 年按產品（外用、口服、敷料）、配銷通路（醫院藥房、零售藥房、線上藥房）和地區分類的放射性皮膚炎市場報告

Radiodermatitis Market Report by Product (Topical, Oral, Dressings), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球放射性皮膚炎市場規模達到4.995億美元。

放射性皮膚炎或放射性皮膚炎是指由於用於治療癌症的放射療法而引起的皮膚病。它通常作為癌症治療期間或介入放射學後的副作用出現在乳腺癌、肺癌、皮膚癌、頸部癌、頭部癌或會陰區癌症患者中，其中皮膚是目標區域的一部分。治療放射性皮膚炎的一些常用產品包括外用抗生素、皮質類固醇、親水性乳膏、水凝膠和水膠體敷料、矽酮塗層敷料、銀葉敷料、口服止痛藥和抗發炎藥物。近年來，放射性皮膚炎治療受到關注，因為它有助於減輕不適、最大限度地減少疼痛並防止正在進行的治療中斷，同時提高患者的整體生活品質。

放射性皮膚炎市場趨勢：

癌症的廣泛流行和擴大採用放射治療作為治療選擇是推動市場成長的主要因素。除此之外，全球老年人口的增加以及對抗放射治療不良副作用的需求不斷成長，都增加了對放射性皮膚炎治療的需求。此外，許多管理和非管理機構正在採取有利舉措，以提高人們對現有放射性皮膚炎治療和管理產品的認知。這與生命科學領域持續研發（R＆D）活動中公共和私人投資的增加相結合，正在促進市場成長。此外，領先企業正專注於開發創新產品變體，以擴大其產品組合併獲得競爭優勢。此外，臨床試驗數量的增加、有利的政府政策、消費者支出能力的提高、醫療基礎設施的改善以及學名藥的容易獲得是創造積極市場前景的其他因素。

本報告回答的關鍵問題

  • 2023年全球放射性皮膚炎市場規模有多大？
  • 2024-2032年全球放射性皮膚炎市場的預期成長率是多少？
  • COVID-19 對全球放射性皮膚炎市場有何影響？
  • 推動全球放射性皮膚炎市場的關鍵因素是什麼？
  • 基於該產品的全球放射性皮膚炎市場的詳細情形如何？
  • 根據配銷通路，全球放射性皮膚炎市場的詳細情形如何？
  • 全球放射性皮膚炎市場的關鍵區域有哪些？
  • 誰是全球放射性皮膚炎市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球放射性皮膚炎市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 專題
    • 市場走向
    • 關鍵環節
      • 皮質類固醇
      • 親水霜
      • 抗生素
      • 其他
    • 市場預測
  • 口服
    • 市場走向
    • 市場預測
  • 敷料
    • 市場走向
    • 關鍵環節
      • 水凝膠和水膠體敷料
      • 無刺阻隔膜
      • 蜂蜜紗布
      • 矽膠塗層敷料
      • 其他
    • 市場預測

第 7 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥房
    • 市場走向
    • 市場預測
  • 網路藥房
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3M Company
    • Bausch Health Companies Inc.
    • Bayer AG
    • BMG PHARMA SpA
    • Charles River Laboratories International Inc.
    • ConvaTec Group plc
    • Helsinn Healthcare SA
    • ICON plc
    • Integra LifeSciences
    • Molnlycke Health Care AB
    • Stratpharma AG
Product Code: SR112024A5638

The global radiodermatitis market size reached US$ 499.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 660.3 Million by 2032, exhibiting a growth rate (CAGR) of 3.06% during 2024-2032.

Radiodermatitis, or radiation dermatitis, refers to a skin condition caused due to radiation therapy used for the treatment of cancer. It generally occurs as a side effect during cancer treatment or after interventional radiology in patients with cancers of the breast, lungs, skin, neck, head or perineum region where the skin is part of the target field. Some of the commonly used products to treat radiodermatitis include topical antibiotics, corticosteroids, hydrophilic creams, hydrogel and hydrocolloid dressings, silicone-coated dressings, silver-leaf dressings, oral analgesics, and anti-inflammatory agents. In recent years, radiodermatitis treatment has gained traction as it helps reduce discomfort, minimize pain and prevent interruption in ongoing therapy while improving the overall quality of the patient's life.

Radiodermatitis Market Trends:

The widespread prevalence of cancer and the rising adoption of radiation therapy as a treatment option represent the primary factors driving the market growth. Besides this, the increasing geriatric population across the globe and the growing need to counter the adverse side effects of radiation therapy are augmenting the demand for radiodermatitis treatment. Additionally, numerous governing and non-governing agencies are taking favorable initiatives to spread awareness regarding the available radiodermatitis treatment and management products. This, in confluence with the rising public and private investments in the ongoing research and development (R&D) activities in the field of life sciences, is catalyzing the market growth. Furthermore, the leading players are focusing on developing innovative product variants to expand their product portfolio and gain a competitive edge. Moreover, the rising number of clinical trials, favorable government policies, increasing consumer expenditure capacities, improving healthcare infrastructure and easy availability of generic drugs are some of the other factors creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global radiodermatitis market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and distribution channel.

Breakup by Product:

Topical

Corticosteroids

Hydrophilic Creams

Antibiotics

Others

Oral

Dressings

Hydrogel and Hydrocolloid Dressings

No Sting Barrier Film

Honey Impregnated Gauze

Silicone Coated Dressings

Others

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Molnlycke Health Care AB and Stratpharma AG.

Key Questions Answered in This Report

  • 1. What was the size of the global radiodermatitis market in 2023?
  • 2. What is the expected growth rate of the global radiodermatitis market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global radiodermatitis market?
  • 4. What are the key factors driving the global radiodermatitis market?
  • 5. What is the breakup of the global radiodermatitis market based on the product?
  • 6. What is the breakup of the global radiodermatitis market based on the distribution channel?
  • 7. What are the key regions in the global radiodermatitis market?
  • 8. Who are the key players/companies in the global radiodermatitis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiodermatitis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Topical
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Corticosteroids
      • 6.1.2.2 Hydrophilic Creams
      • 6.1.2.3 Antibiotics
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Oral
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dressings
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hydrogel and Hydrocolloid Dressings
      • 6.3.2.2 No Sting Barrier Film
      • 6.3.2.3 Honey Impregnated Gauze
      • 6.3.2.4 Silicone Coated Dressings
      • 6.3.2.5 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Bausch Health Companies Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bayer AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 BMG PHARMA S.p.A.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Charles River Laboratories International Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 ConvaTec Group plc
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Helsinn Healthcare SA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 ICON plc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Integra LifeSciences
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Molnlycke Health Care AB
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis
    • 13.3.11 Stratpharma AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Radiodermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Radiodermatitis Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Radiodermatitis Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Radiodermatitis Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Radiodermatitis Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Radiodermatitis (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Radiodermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Radiodermatitis (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Radiodermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Radiodermatitis (Dressings) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Radiodermatitis (Dressings) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Radiodermatitis (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Radiodermatitis (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Radiodermatitis (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Radiodermatitis (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Radiodermatitis (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Radiodermatitis (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: North America: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: North America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: United States: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: United States: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Canada: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Canada: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Asia-Pacific: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Asia-Pacific: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: China: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: China: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Japan: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Japan: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: India: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: India: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: South Korea: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: South Korea: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Australia: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Australia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Indonesia: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Indonesia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Others: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Europe: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Europe: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Germany: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Germany: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: France: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: France: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United Kingdom: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United Kingdom: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Italy: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Italy: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Spain: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Spain: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Russia: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Russia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Latin America: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Latin America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Brazil: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Brazil: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Mexico: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Mexico: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Middle East and Africa: Radiodermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Middle East and Africa: Radiodermatitis Market: Breakup by Country (in %), 2023
  • Figure 67: Middle East and Africa: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Global: Radiodermatitis Industry: SWOT Analysis
  • Figure 69: Global: Radiodermatitis Industry: Value Chain Analysis
  • Figure 70: Global: Radiodermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiodermatitis Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Radiodermatitis Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Radiodermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Radiodermatitis Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Radiodermatitis Market: Competitive Structure
  • Table 6: Global: Radiodermatitis Market: Key Players